Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : The 56 Point TA; Charts With an Attitude -- Ignore unavailable to you. Want to Upgrade?

To: Doug R who wrote (7419)	11/10/1997 3:16:00 PM
From: Sergio H	Read Replies (1) \| Respond to of 79378

Doug, looks like a huge buying opportunity on NOIZ. Is it filling a gap or what? Sergio

To: Doug R who wrote (7419)	11/10/1997 3:26:00 PM
From: B-MAN	Read Replies (2) \| Respond to of 79378

<off topic - re: stoichastic oscillator> does anyone know of any sites, etc... that you can input your own parameters to evaluate a stock's price utilizing this device (for free)? I used to get this from stocksmart.com which as of today... charges. Thanks in advance for your feedback. B

To: Doug R who wrote (7419)	11/10/1997 3:34:00 PM
From: James Strauss	Respond to of 79378

A Blender Candidate... Doug: Imatron (IMAT) looks like it is ready to break out of a two year trading range to the upside... MoneyFlow is positive, and MACD is positive in all time frames... This recent news release signals greater acceptance of Imatron's Heartscan: ................. Wednesday November 5 8:43 AM EST Company Press Release TEXAS RULING PERMITS DIRECT PATIENT ACCESS TO IMATRON'S SUBSIDIARY CENTER HEARTSCAN-HOUSTON SO. SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Nov. 4, 1997-- Self-Referral Now Allowed for Ultrafast CT (R) Coronary Artery Scan Imatron Inc. (NASDAQ:IMAT) said today the Texas Department of Health-Bureau of Radiation Control has changed its official position regarding patient self-referrals for the coronary artery scan, now allowing HeartScan-Houston to accept individuals without physician referral for coronary artery disease risk assessment. Commenting on the new ruling, S. Lewis Meyer, President and CEO of Imatron, said, ''This decision represents a major victory for HeartScan Imaging and the tens of thousands of Texans at risk for heart disease. We are convinced that the Bureau's change in position is, to a large extent, a result of the support for the Ultrafast CT (R) coronary artery scan among leading cardiologists in Houston. These medical professionals recognize our scanner's ability to accurately predict heart attack by non-invasively measuring calcification present in the coronary arteries.'' Major headlines: .......................... National Institutes of Health Propose 10-Year Study of Progression of Subclinical Heart Disease TEXAS RULING PERMITS DIRECT PATIENT ACCESS TO IMATRON'S SUBSIDIARY CENTER HEARTSCAN-HOUSTON AEA Classic to be Held Nov. 2-6 at the Sheraton San Diego Hotel and Marina IMATRON TECHNOLOGY RECEIVES FURTHER VALIDATION AT INTERNATIONAL ATHEROSCLEROSIS SYMPOSIUM IN PARIS Study Shows Imatron Ultrafast CT Scanner Can Track Progression of Coronary Artery Disease IMATRON ACCEPTS PROTOTYPE "REAL-TIME" IMAGE RECONSTRUCTION SYSTEM FROM TERARECON Imatron Posts $0.01 2Q Loss vs. $0.04 loss Imatron's Ultrafast CT Scan Shown To Detect Heart Disease Imatron Posts $0.01 1Q Loss vs. $0.03 loss Jim

To: Doug R who wrote (7419)	11/10/1997 9:47:00 PM
From: coaster	Respond to of 79378

Hi Doug, can I please have your email address again? I believe its at aol but not sure, had a power outage this weekend while online and wiped some mail out. I want to get down to Wil. DE in DEC.,thanks keldog691@aol.com RLLY> I was actually hoping this one would drop back a little so I can pick up some more, a letter I get mentioned RLLY and expects big things in the near future, any thoughts on possible merger with Checkers? good luck, Gary